← Leaderboards
Sara Tartof
University Of California Berkeley
$8,225,332
Attributed
$8,225,332
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2007–24$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,187,532 · 3
CDC$37,800 · 1
By mechanism
R01$7,747,570 · 2
R21$439,962 · 1
R36$37,800 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Berkeley
Same institution · by research overlap
- Ming Chen Hammond$7,514,099
- Jade Benjamin-Chung$2,934,542
- Janelle S Ayres$12,772,910
Others in their field
Top investigators on “California”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$152,313,768
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Sharon A Nachman · Johns Hopkins University$135,132,510
Research focus
CaliforniaIncidenceEvidence BaseCostInnovationRisk FactorsElectronic Health RecordLaboratoriesBaseEffectivenessMemberCaringDesignCharacteristicsInterestUnited StatesCollaborationsCommunicable DiseasesEffectiveness MeasureEducational InterventionAntimicrobial ResistanceCompare EffectivenessEfficacy TrialContinuity Of Patient Care
Grant awards (13)
A New Approach to an Old Problem: Redesigning Latent Tuberculosis Screening and Treatment$760,514
R01 · FY2024 · AI · contact PI
A New Approach to an Old Problem: Redesigning Latent Tuberculosis Screening and Treatment$772,216
R01 · FY2023 · AI · contact PI
A New Approach to an Old Problem: Redesigning Latent Tuberculosis Screening and Treatment$795,819
R01 · FY2022 · AI · contact PI
A New Approach to an Old Problem: Redesigning Latent Tuberculosis Screening and Treatment$798,304
R01 · FY2021 · AI · contact PI
Antimicrobial resistant E. coli before and after California Senate bill 27 (ARES): a natural experiment$716,971
R01 · FY2021 · AI · contact PI
A New Approach to an Old Problem: Redesigning Latent Tuberculosis Screening and Treatment$800,637
R01 · FY2020 · AI · contact PI
Antimicrobial resistant E. coli before and after California Senate bill 27 (ARES): a natural experiment$743,157
R01 · FY2020 · AI · contact PI
Antimicrobial resistant E. coli before and after California Senate bill 27 (ARES): a natural experiment$735,026
R01 · FY2019 · AI · contact PI
Antimicrobial resistant E. coli before and after California Senate bill 27 (ARES): a natural experiment$775,068
R01 · FY2018 · AI · contact PI
Do inpatient antimicrobial stewardship programs help us in the battle against antimicrobial resistance?$205,370
R21 · FY2018 · AI · contact PI
Antimicrobial resistant E. coli before and after California Senate bill 27 (ARES): a natural experiment$849,858
R01 · FY2017 · AI · contact PI
Do inpatient antimicrobial stewardship programs help us in the battle against antimicrobial resistance?$234,592
R21 · FY2017 · AI · contact PI
Streptococcal pharyngitis in slum versus non-slum communities in Salvador Brazil$37,800
R36 · FY2007 · CI · contact PI